Structure-activity relationship for antineoplastic imidazoacridinones: synthesis and antileukemic activity in vivo. 1996

W M Cholody, and B Horowska, and J Paradziej-Lukowicz, and S Martelli, and J Konopa
Department of Pharmaceutical Technology and Biochemistry, Technical University of Gdansk, Gdansk, Poland.

Synthesis of several new 5-amino-substituted derivatives of 5-amino-6H-imidazo[4,5,1-de]-acridin-6-one bearing in the benzene ring OH, OCH3, CH3, tert-butyl, or OCH2O groups is described. 8-OH-substituted compounds or double-substituted 7-OH-10-OCH3 compounds demonstrated potent in vivo activity against murine P388 leukemia. The highest activity was exhibited by 5-[[2-[[2-(diethylamino)ethyl]amino]ethyl]amino]-8-hydroxy-6H- imidazo[4,5,1-de]-acridin-6-one (4c).

UI MeSH Term Description Entries
D007941 Leukemia P388 An experimental lymphocytic leukemia originally induced in DBA/2 mice by painting with methylcholanthrene. P388D(1) Leukemia,P388, Leukemia
D009682 Magnetic Resonance Spectroscopy Spectroscopic method of measuring the magnetic moment of elementary particles such as atomic nuclei, protons or electrons. It is employed in clinical applications such as NMR Tomography (MAGNETIC RESONANCE IMAGING). In Vivo NMR Spectroscopy,MR Spectroscopy,Magnetic Resonance,NMR Spectroscopy,NMR Spectroscopy, In Vivo,Nuclear Magnetic Resonance,Spectroscopy, Magnetic Resonance,Spectroscopy, NMR,Spectroscopy, Nuclear Magnetic Resonance,Magnetic Resonance Spectroscopies,Magnetic Resonance, Nuclear,NMR Spectroscopies,Resonance Spectroscopy, Magnetic,Resonance, Magnetic,Resonance, Nuclear Magnetic,Spectroscopies, NMR,Spectroscopy, MR
D000609 Aminoacridines Acridines which are substituted in any position by one or more amino groups or substituted amino groups.
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus

Related Publications

W M Cholody, and B Horowska, and J Paradziej-Lukowicz, and S Martelli, and J Konopa
January 1992, Journal of medicinal chemistry,
W M Cholody, and B Horowska, and J Paradziej-Lukowicz, and S Martelli, and J Konopa
January 1996, Anti-cancer drug design,
W M Cholody, and B Horowska, and J Paradziej-Lukowicz, and S Martelli, and J Konopa
February 1989, Journal of medicinal chemistry,
W M Cholody, and B Horowska, and J Paradziej-Lukowicz, and S Martelli, and J Konopa
April 1986, Lipids,
W M Cholody, and B Horowska, and J Paradziej-Lukowicz, and S Martelli, and J Konopa
February 1983, Die Pharmazie,
W M Cholody, and B Horowska, and J Paradziej-Lukowicz, and S Martelli, and J Konopa
April 1996, Farmaco (Societa chimica italiana : 1989),
W M Cholody, and B Horowska, and J Paradziej-Lukowicz, and S Martelli, and J Konopa
May 1996, Molecular pharmacology,
W M Cholody, and B Horowska, and J Paradziej-Lukowicz, and S Martelli, and J Konopa
October 2023, European journal of medicinal chemistry,
W M Cholody, and B Horowska, and J Paradziej-Lukowicz, and S Martelli, and J Konopa
January 1985, Journal of medicinal chemistry,
W M Cholody, and B Horowska, and J Paradziej-Lukowicz, and S Martelli, and J Konopa
November 1997, Biochemistry and molecular biology international,
Copied contents to your clipboard!